Nuevolution CEO on million-dollar offer from Amgen: "It's the result of many years' work"

CEO in Danish Nuevolution, Alex Gouliaev, credits his employees for Amgen's offer to acquire the company for USD 167 million. He hopes that he and most staff members will continue their work under the new leadership, which is to speed up development in the Danish company.

Photo: Nuevolution PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles